Subscribe to the gold package and get unlimited access to Shamra Academy
Register a new userOptimal Semi-supervised Estimation and Inference for High-dimensional Linear Regression
86
0
0.0
(
0
)
Added by
Yang Ning
Publication date
2020
fields
Mathematical Statistics
and research's language is
English
Ask ChatGPT about the research
No Arabic abstract
There are many scenarios such as the electronic health records where the outcome is much more difficult to collect than the covariates. In this paper, we consider the linear regression problem with such a data structure under the high dimensionality. Our goal is to investigate when and how the unlabeled data can be exploited to improve the estimation and inference of the regression parameters in linear models, especially in light of the fact that such linear models may be misspecified in data analysis. In particular, we address the following two important questions. (1) Can we use the labeled data as well as the unlabeled data to construct a semi-supervised estimator such that its convergence rate is faster than the supervised estimators? (2) Can we construct confidence intervals or hypothesis tests that are guaranteed to be more efficient or powerful than the supervised estimators? To address the first question, we establish the minimax lower bound for parameter estimation in the semi-supervised setting. We show that the upper bound from the supervised estimators that only use the labeled data cannot attain this lower bound. We close this gap by proposing a new semi-supervised estimator which attains the lower bound. To address the second question, based on our proposed semi-supervised estimator, we propose two additional estimators for semi-supervised inference, the efficient estimator and the safe estimator. The former is fully efficient if the unknown conditional mean function is estimated consistently, but may not be more efficient than the supervised approach otherwise. The latter usually does not aim to provide fully efficient inference, but is guaranteed to be no worse than the supervised approach, no matter whether the linear model is correctly specified or the conditional mean function is consistently estimated.
rate research
Read More
We study a mean-field spike and slab variational Bayes (VB) approximation to Bayesian model selection priors in sparse high-dimensional linear regression. Under compatibility conditions on the design matrix, oracle inequalities are derived for the mean-field VB approximation, implying that it converges to the sparse truth at the optimal rate and gives optimal prediction of the response vector. The empirical performance of our algorithm is studied, showing that it works comparably well as other state-of-the-art Bayesian variable selection methods. We also numerically demonstrate that the widely used coordinate-ascent variational inference (CAVI) algorithm can be highly sensitive to the parameter updating order, leading to potentially poor performance. To mitigate this, we propose a novel prioritized updating scheme that uses a data-driven updating order and performs better in simulations. The variational algorithm is implemented in the R package sparsevb.
Heterogeneity is an important feature of modern data sets and a central task is to extract information from large-scale and heterogeneous data. In this paper, we consider multiple high-dimensional linear models and adopt the definition of maximin effect (Meinshausen, B{u}hlmann, AoS, 43(4), 1801--1830) to summarize the information contained in this heterogeneous model. We define the maximin effect for a targeted population whose covariate distribution is possibly different from that of the observed data. We further introduce a ridge-type maximin effect to simultaneously account for reward optimality and statistical stability. To identify the high-dimensional maximin effect, we estimate the regression covariance matrix by a debiased estimator and use it to construct the aggregation weights for the maximin effect. A main challenge for statistical inference is that the estimated weights might have a mixture distribution and the resulted maximin effect estimator is not necessarily asymptotic normal. To address this, we devise a novel sampling approach to construct the confidence interval for any linear contrast of high-dimensional maximin effects. The coverage and precision properties of the proposed confidence interval are studied. The proposed method is demonstrated over simulations and a genetic data set on yeast colony growth under different environments.
Labeling patients in electronic health records with respect to their statuses of having a disease or condition, i.e. case or control statuses, has increasingly relied on prediction models using high-dimensional variables derived from structured and unstructured electronic health record data. A major hurdle currently is a lack of valid statistical inference methods for the case probability. In this paper, considering high-dimensional sparse logistic regression models for prediction, we propose a novel bias-corrected estimator for the case probability through the development of linearization and variance enhancement techniques. We establish asymptotic normality of the proposed estimator for any loading vector in high dimensions. We construct a confidence interval for the case probability and propose a hypothesis testing procedure for patient case-control labelling. We demonstrate the proposed method via extensive simulation studies and application to real-world electronic health record data.
Semi-supervised (SS) inference has received much attention in recent years. Apart from a moderate-sized labeled data, L, the SS setting is characterized by an additional, much larger sized, unlabeled data, U. The setting of |U| >> |L|, makes SS inference unique and different from the standard missing data problems, owing to natural violation of the so-called positivity or overlap assumption. However, most of the SS literature implicitly assumes L and U to be equally distributed, i.e., no selection bias in the labeling. Inferential challenges in missing at random (MAR) type labeling allowing for selection bias, are inevitably exacerbated by the decaying nature of the propensity score (PS). We address this gap for a prototype problem, the estimation of the responses mean. We propose a double robust SS (DRSS) mean estimator and give a complete characterization of its asymptotic properties. The proposed estimator is consistent as long as either the outcome or the PS model is correctly specified. When both models are correctly specified, we provide inference results with a non-standard consistency rate that depends on the smaller size |L|. The results are also extended to causal inference with imbalanced treatment groups. Further, we provide several novel choices of models and estimators of the decaying PS, including a novel offset logistic model and a stratified labeling model. We present their properties under both high and low dimensional settings. These may be of independent interest. Lastly, we present extensive simulations and also a real data application.
The purpose of this paper is to construct confidence intervals for the regression coefficients in the Fine-Gray model for competing risks data with random censoring, where the number of covariates can be larger than the sample size. Despite strong motivation from biomedical applications, a high-dimensional Fine-Gray model has attracted relatively little attention among the methodological or theoretical literature. We fill in this gap by developing confidence intervals based on a one-step bias-correction for a regularized estimation. We develop a theoretical framework for the partial likelihood, which does not have independent and identically distributed entries and therefore presents many technical challenges. We also study the approximation error from the weighting scheme under random censoring for competing risks and establish new concentration results for time-dependent processes. In addition to the theoretical results and algorithms, we present extensive numerical experiments and an application to a study of non-cancer mortality among prostate cancer patients using the linked Medicare-SEER data.
Log in to be able to interact and post comments
comments
Fetching comments
Sign in to be able to follow your search criteria
